CASI Pharmaceuticals Q1 EPS $(0.71) Misses $(0.05) Estimate, Sales $3.41M Miss $12.00M Estimate
CASI Pharmaceuticals Q1 EPS $(0.71) Misses $(0.05) Estimate, Sales $3.41M Miss $12.00M Estimate
CASI Pharmicals第一季度每股收益美元（0.71美元）未達到預期（0.05美元），銷售額爲341萬美元，低於1,200萬美元的預期
CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.71) per share which missed the analyst consensus estimate of $(0.05) by 1320 percent. This is a 57.78 percent decrease over losses of $(0.45) per share from the same period last year. The company reported quarterly sales of $3.41 million which missed the analyst consensus estimate of $12.00 million by 71.59 percent. This is a 59.16 percent decrease over sales of $8.35 million the same period last year.
CASI製藥公司（納斯達克股票代碼：CASI）公佈的季度虧損爲每股0.71美元（0.71美元），比分析師普遍預期的0.05美元（0.05美元）低1320個百分點。這比去年同期每股虧損0.45美元（0.45美元）下降了57.78％。該公司公佈的季度銷售額爲341萬美元，比分析師普遍預期的1,200萬美元低71.59％。這比去年同期的835萬美元銷售額下降了59.16％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。